AUTHOR OF THIS BLOG

DR ANTHONY MELVIN CRASTO, WORLDDRUGTRACKER

Novo buys Norway’s Xellia for $700 million

 companies  Comments Off on Novo buys Norway’s Xellia for $700 million
May 222013
 

Novo A/S, the holding company of Denmark’s Novo Nordisk, has acquired Xellia Pharmaceuticals of Norway in a deal valued at $700 million.

read all at

http://www.pharmatimes.com/Article/13-05-21/Novo_buys_Norway_s_Xellia_for_700_million.aspx

Share
Follow

Get every new post on this blog delivered to your Inbox.

Join other followers: